Journal Article
Medicare Part D Preferred Pharmacy Networks And The Risk For Pharmacy Closure, 2014–23
May 5, 2025
Featured Experts: Genevieve P. Kanter, PhD, Dima M. Qato, PharmD, MPH, PhD
Research
All Research Featured Research
Perspective
A Missed Chance to Make America Healthier and Richer
April 7, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
Perspective
Medicare Advantage is Covering More and More Americans—Some Because They Don’t Get to Choose
April 3, 2025
Featured Experts: Grace Mackleby (née McCormack), PhD, Victoria Shier, PhD
Journal Article
Cost Sharing for Preferred Branded Drugs in Medicare Part D
February 14, 2025
Featured Experts: Erin Trish, PhD
News
Medicare Beneficiaries Face Much Higher Drug Costs as Plans Quickly Shift to Coinsurance
February 14, 2025
Featured Experts: Erin Trish, PhD
Perspective
Medicare Drug Price Negotiations Need Something New: A Floor
January 22, 2025
Featured Experts: Darius Lakdawalla, PhD
Comment Letter
Comments to CMS on Proposed $2 Drug List Model
December 9, 2024
Featured Experts: Geoffrey Joyce, PhD, Julie Zissimopoulos, PhD
News
Most Medicare Beneficiaries Do Not Compare Prescription Drug Plans – And May Be Sticking with Bad Plans
November 19, 2024
Featured Experts: Wändi Bruine de Bruin, MSc, PhD, Erin Trish, PhD, Dana Goldman, PhD
Journal Article
Medicare Part D Beneficiaries’ Self-reported Barriers to Switching Plans and Making Plan Comparisons at All
November 19, 2024
Featured Experts: Wändi Bruine de Bruin, MSc, PhD, Daniel Czarnowske, PhD, Daniel McFadden, PhD
News
Out-of-Pocket Costs Are Substantially Lower in Medicare Advantage Than Traditional Medicare
November 4, 2024
Featured Experts: Erin Trish, PhD
Journal Article
Expected Out-Of-Pocket Costs: Comparing Medicare Advantage With Fee-For-Service Medicare
November 4, 2024
Featured Experts: Erin Trish, PhD
Journal Article
The Inflation Reduction Act and Patient Costs for Drugs to Treat Heart Failure
October 29, 2024
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
Perspective
Medicare vs. Medicare Advantage: The Choices Can Be Overwhelming
October 10, 2024
Featured Experts: Grace Mackleby (née McCormack), PhD
Journal Article
Shingles Vaccination in Medicare Part D After Inflation Reduction Act Elimination of Cost Sharing
May 23, 2024
Featured Experts: Dima M. Qato, PharmD, MPH, PhD, John Romley, PhD, Rebecca Myerson, PhD, MPH, Dana Goldman, PhD
News
Medicare Part D Plans Increased Restrictions on Drug Coverage
March 4, 2024
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
Journal Article
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011–20
March 4, 2024
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
Testimony
Testimony on Ensuring Affordable and Valuable Pharmaceutical Innovation for Americans
February 8, 2024
Featured Experts: Darius Lakdawalla, PhD
Perspective
The Inflation Reduction Act’s Harms Go Beyond Drug Pricing — They’re Threatening Your Medicare
December 23, 2023
Featured Experts: Joseph Grogan, JD
Journal Article
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market
August 14, 2023
Featured Experts: Neeraj Sood, PhD
- ← Previous
- 1
- 2
- 3
- 4
- Next →